publicly traded companies glp-1 receptor agonist manufacturers Market Size, Share & Forecast, 2026–2034 GLP-1 Receptor Agonist Market Growth

To find out if your insurance company covers GLP-1 medications, reach out to them directly to ask

Viking Therapeutics Today VKTX Viking Therapeutics $37.08 +0.71 (+1.95%) As of 07/17/2026 04:00 PM Eastern 52-Week Range $22.96 $43.15 Price Target $93.60 Viking is developing VK2735 in both oral and injectable forms and should begin Phase 3 trials for the oral form in the coming months

Note: Prices can vary depending on the pharmacy, location, and dosage

And immediately, there was just a complete shift in my energy, and the response was great

Retrieved from Horn, D

Growth dynamics differ based on regulatory approval timelines, reimbursement frameworks, obesity prevalence, and healthcare infrastructure development